Gainers & Losers
Mon Apr 21 2025 09:59:57- Tech Mahindra share price
- ₹1,370.004.91%
- Indusind Bank share price
- ₹828.054.24%
- Power Grid Corporation Of ...
- ₹319.953.61%
- Bajaj Finserv share price
- ₹2,105.053.51%
- Mahindra And Mahindra share price
- ₹2,767.303.28%
Active Stocks
Mon Apr 21 2025 09:59:45- Crompton Greaves Consumer ...
- ₹339.702.29%
- Zee Entertainment Enterpri...
- ₹118.753.90%
- Tata Steel share price
- ₹139.201.49%
- Indian Oil Corp share price
- ₹138.653.24%
- Bharat Electronics share price
- ₹300.051.68%
Business News/Market/Market Stats/Alembic Pharmaceuticals share price/ Alembic Pharmaceuticals Profit Loss Annual
Alembic Pharmaceuticals Profit & Loss Annual
Trade848.10 -2.05 (-0.24%)Updated : 21 Apr 2025
| Fiscal Period | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
| Revenue | 6,228.63 | 5,652.62 | 5,305.79 | 5,393.13 |
| Total Revenue | 6,228.63 | 5,652.62 | 5,305.79 | 5,393.13 |
| Costof Revenue Total | 2,174.07 | 2,174.70 | 1,844.03 | 1,639.99 |
| Gross Profit | 4,054.56 | 3,477.92 | 3,461.76 | 3,753.14 |
| Selling/ General/ Admin Expenses Total | 2,715.31 | 2,178.21 | 1,945.86 | 1,745.86 |
| Research Development | 384.45 | 568.93 | 628.99 | 518.57 |
| Depreciation/ Amortization | 272.67 | 275.43 | 286.78 | 183.47 |
| Unusual Expense( Income) | 0.00 | 0.00 | - | - |
| Other Operating Expenses Total | 21.40 | 17.57 | 12.67 | 8.41 |
| Total Operating Expense | 5,567.90 | 5,214.84 | 4,718.33 | 4,096.30 |
| Operating Income | 660.73 | 437.78 | 587.46 | 1,296.83 |
| Interest Inc( Exp) Net- Non- Op Total | -32.99 | -80.10 | 31.18 | 69.12 |
| Gain( Loss)on Saleof Assets | 1.70 | -4.70 | 0.54 | 1.39 |
| Other Net | 2.39 | 1.61 | 0.93 | 0.74 |
| Net Income Before Taxes | 631.83 | 354.59 | 620.11 | 1,368.08 |
| Provisionfor Income Taxes | 16.00 | 12.61 | 104.46 | 253.32 |
| Net Income After Taxes | 615.83 | 341.98 | 515.65 | 1,114.76 |
| Net Income Before Extra Items | 615.83 | 341.98 | 520.93 | 1,146.50 |
| Net Income | 615.83 | 341.98 | 520.93 | 1,146.50 |
| Total Adjustmentsto Net Income | -0.10 | 0.10 | 0.10 | - |
| Income Availableto Com Excl Extra Ord | 615.82 | 341.99 | 520.94 | 1,146.50 |
| Income Availableto Com Incl Extra Ord | 615.82 | 341.99 | 520.94 | 1,146.50 |
| Diluted Net Income | 615.82 | 341.99 | 520.94 | 1,146.50 |
| Diluted Weighted Average Shares | 19.66 | 19.66 | 19.66 | 19.37 |
| Diluted EPS Excluding Extra Ord Items | 31.33 | 17.40 | 26.50 | 59.18 |
| DPS- Common Stock Primary Issue | 11.00 | 8.00 | 10.00 | 14.00 |
| Diluted Normalized EPS | 31.25 | 17.63 | 26.48 | 59.12 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| period Type | - | - | - | - |
| Equity In Affiliates | - | - | 5.28 | 31.74 |
*All figures in crores except per share values
Alembic Pharmaceuticals Quick Links
Alembic Pharmaceuticals Dividend Alembic Pharmaceuticals Bonus Alembic Pharmaceuticals News Alembic Pharmaceuticals AGM Alembic Pharmaceuticals Rights Alembic Pharmaceuticals Splits Alembic Pharmaceuticals Board Meetings Alembic Pharmaceuticals Key Metrics Alembic Pharmaceuticals Shareholdings Alembic Pharmaceuticals Balance Sheet Alembic Pharmaceuticals Cashflow Alembic Pharmaceuticals Q1 Results Alembic Pharmaceuticals Q2 Results Alembic Pharmaceuticals Q3 Results Alembic Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
1,370.00+64.15(4.91%)
828.05+33.65(4.24%)
319.95+11.15(3.61%)
422.80-4.45 (-1.04%)
2,350.00-24.65 (-1.04%)